These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8089810)

  • 21. Proliferative activity as revealed by Ki-67 in uterine adenocarcinoma of endometrioid type: comparison of tumours from patients with and without previous oestrogen therapy.
    Nielsen AL; Nyholm HC
    J Pathol; 1993 Nov; 171(3):199-205. PubMed ID: 8277369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation.
    Porschen R; Classen S; Piontek M; Borchard F
    Cancer Res; 1994 Jan; 54(2):587-91. PubMed ID: 8275498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
    Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
    J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry.
    Parrado C; Falkmer UG; Höög A; Falkmer S; Ahrens O; Rius F; Grimelius L
    Gen Diagn Pathol; 1996 Mar; 141(3-4):215-27. PubMed ID: 8705786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A simple method for flow cytometric measurement of Ki-67 reactive antigen on small solid tissues].
    Murakami T; Oga A; Uchiyama T; Kimura Y; Morimoto H; Suzuki T; Takahashi M
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):737-40. PubMed ID: 7683864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of metallothionein expression in non-small cell lung carcinomas.
    Dziegiel P; Jeleń M; Muszczyńska B; Maciejczyk A; Szulc A; Podhorska-Okołów M; Cegielski M; Zabel M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():43-5. PubMed ID: 15638370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity.
    Gonzalez-Moles MA; Caballero R; Rodriguez-Archilla A; Ruiz-Avila I; Bravo I
    Acta Stomatol Belg; 1996 Dec; 93(4):159-65. PubMed ID: 9658636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
    Kunz J; Schmidt A
    Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inverted transitional-cell papilloma: the expression of the Ki-67 nuclear antigen as a prognostic factor].
    Valero Puerta JA; Redondo Martínez E; Jieménez González C; Gómez Medina ML; Martínez de la Riva SI
    Arch Esp Urol; 1995 Nov; 48(9):887-92. PubMed ID: 8554393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of TGF-beta 1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas.
    Hagedorn H; Sauer U; Schleicher E; Nerlich A
    Anticancer Res; 1999; 19(5B):4265-72. PubMed ID: 10628385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations.
    Liu J; Farhood A
    Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical detection of proliferative cells.
    Mokrý J; Nĕmecek S
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.